Emend (Aprepitant Oral Suspension) and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Emend (Aprepitant Oral Suspension) and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Emend, Cinvanti, Emend 3-Day, Emend 2-Day
Synonyms: Emend
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emend (Aprepitant Oral Suspension)-Insulin degludec
- Emend (Aprepitant Oral Suspension)-Insulin Degludec (U-100) Prefilled Pens
- Emend (Aprepitant Oral Suspension)-Insulin Degludec (U-100) Vials
- Emend (Aprepitant Oral Suspension)-Insulin Degludec (U-200) Prefilled Pens
- Emend (Aprepitant Oral Suspension)-Insulin degludec and liraglutide
- Emend (Aprepitant Oral Suspension)-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Emend (Fosaprepitant)
- Insulin aspart, recombinant Subcutaneous-Emend for Injection
- Insulin aspart, recombinant Subcutaneous-Emend Intravenous
- Insulin aspart, recombinant Subcutaneous-Emflaza
- Insulin aspart, recombinant Subcutaneous-Emflaza (Deflazacort Oral Suspension)
- Insulin aspart, recombinant Subcutaneous-Emflaza (Deflazacort Tablets)